Publication | Open Access
Randomized, Double-Blind Study Comparing Proposed Biosimilar La-Ep2006 with Reference Pegfilgrastim in Breast Cancer
37
Citations
10
References
2016
Year
LA-EP2006 and reference pegfilgrastim showed no clinically meaningful differences regarding efficacy and safety in breast cancer patients receiving chemotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1